London Stock Exchange welcomes Egypt’s Integrated Diagnostics Holdings

London Stock Exchange welcomes Egypt’s Integrated Diagnostics Holdings

  • IDHC becomes first Egyptian healthcare company to complete a UK offering
  • Second listing by an Egyptian company in London this year
  • Third healthcare company from the MENA region to list in London

London Stock Exchange formally welcomed Egypt’s Integrated Diagnostics Holdings (IDHC) to its markets today. The Cairo-based company, which operates 283 medical testing and radiology laboratories raised $290m in an initial public offering. IDHC’s market capitalisation on completion of the public offer was $668m and rose to $880m, an increase of 26 per cent on its first day of trading. The listing was 12 times oversubscribed.

IDHC is the second Egyptian company to list in London in 2015 after packaged snack manufacturer, Edita’s successful dual-listing in London and Cairo in April. IDHC is the first Egyptian healthcare company and the third such company from the MENA region to list in London, after NMC Healthcare in 2012 and Al Noor Hospitals in 2013.

Ibukun Adebayo, Head of Primary Markets, Middle East & Africa, London Stock Exchange Group said:

“IDHC’s successful listing demonstrates London investors’ continued ability and desire to support growth stories from Egypt and across the region. We expect that listings such as IDHC’s will encourage more ambitious, internationally focused companies to raise capital in London.”

In addition to IDHC there are ten Egyptian companies on London’s markets with a combined market capitalisation of over $24 billion.


- ends -

For further information:







Tom Gilbert

+44 (0)20   7797 1222

Notes to editors:

About London Stock Exchange Group:

London Stock Exchange Group (LSE.L) is a diversified international market infrastructure and capital markets business sitting at the heart of the world's financial community. The Group can trace its history back to 1698.

The Group operates a broad range of international equity, bond and derivatives markets, including London Stock Exchange; Borsa Italiana; MTS, Europe's leading fixed income market; and Turquoise, a pan-European equities MTF. It is also home to one of the world’s leading growth markets for SMEs, AIM. Through its platforms, the Group offers international business and investors unrivalled access to Europe's capital markets.

Post trade and risk management services are a significant part of the Group’s business operations. In addition to majority ownership of multi-asset global CCP operator, LCH.Clearnet Group, LSEG operates CC&G, the Italian clearing house; Monte Titoli, the T2S-ready European settlement business; and globeSettle, the Group’s newly established CSD based in Luxembourg.

The Group is a global leader in indexing and analytic solutions. FTSE and Russell Indexes offer thousands of indices that measure and benchmark markets around the world. The Group also provides customers with an extensive range of real time and reference data products, including SEDOL, UnaVista, Proquote and RNS.

Following the acquisition of Russell Investments, LSEG conducted a comprehensive review of the investment management business to analyse its strategic fit with the Group. This was concluded in February 2015, and LSEG is now exploring a sale of the business in its entirety.

London Stock Exchange Group is a leading developer of high performance trading platforms and capital markets software for customers around the world. In addition to the Group’s own markets, over 35 other organisations and exchanges use the Group’s MillenniumIT trading, surveillance and post trade technology.

Headquartered in London, with significant operations in North America, Italy, France and Sri Lanka, the Group employs approximately 4,700 people.

Further information on London Stock Exchange Group can be found at